Webinar: What Is Needed to Realize the Potential of Organoids?

From standardisation of imaging techniques, to more reproducible and cost-effective organoid culture media

Organoids have the potential to revolutionise current drug discovery approaches, enhance the physiological relevance of in vitro disease models, and deliver on the promise of precision medicine. But, as with any new technology, there are a number of hurdles to overcome as pharma and biotech look to scale-up their organoid models and incorporate them routinely into their assay workflows.

CytoSMART and Qkine have partnered with organoid pioneers from both academia and industry to facilitate an open and collaborative discussion about the key challenges facing pharma and biotech companies as they approach this pivotal stage of their organoid R&D programmes.

In this free webinar, we’ll be covering:

  • The opportunities organoids offer and the challenges faced when scaling up applications, including standardisation of imaging techniques
  • The need for more reproducible, cost-effective chemically-defined organoid culture media to support the seamless transition from bench to clinical-based applications
  • The latest imaging technologies from CytoSMART to enhance organoid research
  • How Qkine is optimising key organoid growth factors for more reproducible, animal-free organoid culture media
  • Live Q&A session with organoid experts from Cold Spring Harbor Laboratory, Stemnovate and Hubrecht Organoid Technology (HUB)

Speakers:

🎙️Dr. René Overmeer from Hubrecht Organoid Technology: “Reliable High throughput screening using organoids”
🎙️Dr. Dennis Plenker from Cold Spring Harbor Laboratory: “Human organoid growth conditions – from media to organoid cultures”
🎙️Dr. Ruchi Sharma from Stemnovate Limited: “Tissue engineering, organoids or organ systems: challenges and opportunities”
🎙️Rob Nixon from Qkine: “Re-defining growth factor & cytokine biochemical quality”
🎙️Dr. Inge Thijssen – van Loosdregt from CytoSMART Technologies B.V.: “Enhancing organoid research using novel bright-field imaging devices”

Date/time

  • Tuesday 13th October
  • 10am EDT/3pm BST/4pm CEST
  • 1h including live Q&A
  • Online
  • Free to attend

Don’t miss out – reserve your place today! Register now

October 21, 2020 Webinar: Drug Discovery Powered by HUB Organo... Drug Discovery Powered by HUB Organoids and OcellO 3D Image Analysis Summary: More clinically relevant models are urgent... read more
September 04, 2020 HUB and BGI-Qingdao sign a Memorandum of Unde... Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced today that they ... read more
May 27, 2020 Studying the development of ovarian cancer wi... read more